Sign in
4

Changes in Ownership

Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-18-018386

President and General Counsel acquired 39,919 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shandell Jason B. President and General Counsel 2018-03-15 Grant or award +39,919 256,867 D
Derivatives
Shandell Jason B. President and General Counsel 2018-03-15 Grant or award · Employee Stock Option (right to buy) +92,692 92,692 D
Loading xslF345X03/a4.xml…